Zhuyun Zhao

Zhuyun Zhao

Auto-generated profile, based on publicly available information

Zhuyun Zhao

Department of Burn and Plastic Surgery

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ZZZhuyun Zhao
Zhuyun Zhao
PZPeng Zhang
Peng Zhang
WLWei Li
Wei Li
DWDengchuan Wang
Dengchuan Wang
CKChangneng Ke
Changneng Ke
SXShi Xu
Shi Xu
Bladder cancer is one of the most commonly diagnosed cancers worldwide, especially in males. Current therapeutic interventions, including surgery, radiation therapy, chemotherapy, and immunotherapy, have not been able to improve the clinical outcome of bladder cancer patients with satisfaction. Recombinant human arginase (rhArg, BCT‐100) is a novel agent with great anticancer effects on arginine‐auxotrophic tumors. However, the effects of BCT‐100 on bladder cancer remain unclear. In this study, the in vitro anticancer effects of BCT‐100 were assessed using four bladder cancer cell lines (J82, SCaBER, T24, and 5637), while the in vivo effects were evaluated by establishing T24 nude mice xenograft models. Intracellular arginine level was observed to be sharply decreased followed by the onset of apoptotic events. Furthermore, BCT‐100 was found to induce H2O2 production and mitochondrial membrane depolarization, leading to the release of mitochondrial cytochrome c and Smac to the cytosol. Treatment with BCT was observed to upregulate the expression of LC3B and Becllin‐1, but downregulate the expression of p62 in a time‐dependent manner. Autophagic flux was also observed upon BCT‐100 treatment. Besides, the phosphorylation of the AKT/mTOR pathway was suppressed in a time‐dependent fashion in BCT‐100‐treated T24 cells. While N‐acetyl‐L‐cysteine was shown to alleviate BCT‐100‐induced apoptosis and autophagy, chloroquine, MK‐2206, and rapamycin were found to potentiate BCT‐100‐triggered apoptosis. Finally, BCT‐100 was demonstrated to induce autophagy and apoptosis via the ROS‐mediated AKT/mTOR signaling pathway in bladder cancer cells.